226
Views
38
CrossRef citations to date
0
Altmetric
Review

Selecting multimodal therapy for rhabdomyosarcoma

&
Pages 1285-1301 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Robert Nakayama, Tomoaki Mori, Yusuke Okita, Yutaka Shiraishi & Makoto Endo. (2020) A multidisciplinary approach to soft-tissue sarcoma of the extremities. Expert Review of Anticancer Therapy 20:10, pages 893-900.
Read now
Andrea Ferrari, Gianni Bisogno, Cristina Meazza, Marco Vajna de Pava, Iyad Sultan, Gian Luca De Salvo, Carlo Alfredo Clerici, Laura Veneroni & Michela Casanova. (2012) The challenge of access to care for soft tissue sarcomas bridging pediatric and adult age: the Italian pediatric oncology view. Expert Review of Anticancer Therapy 12:2, pages 243-254.
Read now

Articles from other publishers (36)

Alia Mousli, Emna Boudhina, Ines Lasmar, Fadoua Bouguerra, Yosr Zenzri, Rim Abidi, Chiraz Nasr & Amel Mezlini. (2023) Rhabdomyosarcoma in Uterine Cervix: A 30-Year-Old Tunisian Woman Case Report. Reports of Radiotherapy and Oncology 9:1.
Crossref
Hen Moshe Halamish, Ivan Zlotver & Alejandro Sosnik. (2022) Polymeric nanoparticles surface-complexed with boric acid actively target solid tumors overexpressing sialic acid. Journal of Colloid and Interface Science 626, pages 916-929.
Crossref
Ezra Hahn, Shivali Barot, Brian O'Sullivan, Shao Hui Huang, Abha Gupta, Ali Hosni, Albiruni Abdul Razak, John Waldron, Jonathan Irish, Patrick Gullane, Dale Brown, Ralph Gilbert, John R. de Almeida, Derek Tsang & David B. Shultz. (2022) Adult Head and Neck Rhabdomyosarcoma: Management, Outcomes, and the Effect of Intensity Modulated Radiation Therapy on Locoregional Control. Advances in Radiation Oncology 7:6, pages 101055.
Crossref
AnkitaRungta Kapoor, Manish Chandra, Rajendra Bhalavat, Chetna Bakshi, Chetan Anchan, Pratibha Bauskar & Saurabh Markana. (2022) Pediatric extremity rhabdomyosarcoma treated with re-brachytherapy in recurrent setting. Journal of Cancer Research and Therapeutics 18:3, pages 812.
Crossref
Bas Vaarwerk, Willemijn B Breunis, Lianne M Haveman, Bart de Keizer, Nina Jehanno, Lise Borgwardt, Rick R van Rijn, Henk van den Berg, Jérémie F Cohen, Elvira C van Dalen & Johannes HM Merks. (2021) Fluorine-18-fluorodeoxyglucose (FDG) positron emission tomography (PET) computed tomography (CT) for the detection of bone, lung, and lymph node metastases in rhabdomyosarcoma. Cochrane Database of Systematic Reviews 2021:11.
Crossref
Simona Camero, Giulia Vitali, Paola Pontecorvi, Simona Ceccarelli, Eleni Anastasiadou, Francesca Cicchetti, Elisabetta Flex, Silvia Pomella, Matteo Cassandri, Rossella Rota, Francesco Marampon, Cinzia Marchese, Amalia Schiavetti & Francesca Megiorni. (2021) DNMT3A and DNMT3B Targeting as an Effective Radiosensitizing Strategy in Embryonal Rhabdomyosarcoma. Cells 10:11, pages 2956.
Crossref
Carola A. S. Arndt, Ewa Koscielniak & Gianni Bisogno. 2021. Sarcomas of Bone and Soft Tissues in Children and Adolescents. Sarcomas of Bone and Soft Tissues in Children and Adolescents 53 63 .
Carola A. S. Arndt & Andrea Ferrari. 2021. Sarcomas of Bone and Soft Tissues in Children and Adolescents. Sarcomas of Bone and Soft Tissues in Children and Adolescents 37 46 .
Clara Perrone, Silvia Pomella, Matteo Cassandri, Maria Rita Braghini, Michele Pezzella, Franco Locatelli & Rossella Rota. (2020) FAK Signaling in Rhabdomyosarcoma. International Journal of Molecular Sciences 21:22, pages 8422.
Crossref
Laxman Pandey, Deepa Joseph, Rajnish Arora, Ashok Singh, Naseef Kassim, Rajesh Pasricha & Manoj Gupta. (2020) Primary pineal rhabdomyosarcoma in an adult male patient: A rare presentation and review of the literature. Clinical Neurology and Neurosurgery 196, pages 106044.
Crossref
Ruping Zhao, Xiaoli Yu, Yan Feng, Jian Wang, Yong Chen, Yanjiao Mao, Wei Yin, Zhen Zhang, Xiaomao Guo & Shenglin Ma. (2020) The survival benefit of radiotherapy in localized primary adult rhabdomyosarcoma. Asia-Pacific Journal of Clinical Oncology 16:4, pages 266-272.
Crossref
Andrea Ferrari, Ines B. Brecht, Gemma Gatta, Dominik T. Schneider, Daniel Orbach, Giovanni Cecchetto, Jan Godzinski, Yves Reguerre, Ewa Bien, Teresa Stachowicz-Stencel, Michael Ost, Chiara Magni, Pamela Kearns, Gilles Vassal, Maura Massimino, Andrea Biondi, Gianni Bisogno & Annalisa Trama. (2019) Defining and listing very rare cancers of paediatric age: consensus of the Joint Action on Rare Cancers in cooperation with the European Cooperative Study Group for Pediatric Rare Tumors. European Journal of Cancer 110, pages 120-126.
Crossref
Giulia Bertolini, Luca Bergamaschi, Andrea Ferrari, Salvatore L. Renne, Paola Collini, Cecilia Gardelli, Marta Barisella, Giovanni Centonze, Stefano Chiaravalli, Cinzia Paolino, Massimo Milione, Maura Massimino, Michela Casanova & Patrizia Gasparini. (2018) PD-L1 assessment in pediatric rhabdomyosarcoma: a pilot study. BMC Cancer 18:1.
Crossref
Gianni Bisogno, Meriel Jenney, Christophe Bergeron, Soledad Gallego Melcón, Andrea Ferrari, Odile Oberlin, Modesto Carli, Michael Stevens, Anna Kelsey, Angela De Paoli, Mark N Gaze, Helene Martelli, Christine Devalck, Johannes H Merks, Myriam Ben-Arush, Heidi Glosli, Julia Chisholm, Daniel Orbach, Veronique Minard-Colin, Gian Luca De Salvo, Maja Cesen, Adriana Rose, Sima Ferman, Peter Mudry, Daniela Sejnova, Paola Dal Bianco, Ilaria Zanetti, Felix Niggli, Timothy Rogers, Giovanni Cecchetto, Federica De Corti, Florent Guerin, Sheila Terwisscha, Dominique Ranchere, Rita Alaggio, Janet Shipley, Angelo Rosolen, Henry Mandeville, Giovanni Scarzello, Valerie Bernier & Kieran McHugh. (2018) Addition of dose-intensified doxorubicin to standard chemotherapy for rhabdomyosarcoma (EpSSG RMS 2005): a multicentre, open-label, randomised controlled, phase 3 trial. The Lancet Oncology 19:8, pages 1061-1071.
Crossref
Carola A.S. Arndt, Gianni Bisogno & Ewa Koscielniak. (2018) Fifty years of rhabdomyosarcoma studies on both sides of the pond and lessons learned. Cancer Treatment Reviews 68, pages 94-101.
Crossref
Andrea Ferrari, Archie Bleyer, Shreyaskumar Patel, Stefano Chiaravalli, Patrizia Gasparini & Michela Casanova. (2018) The challenge of the management of adolescents and young adults with soft tissue sarcomas. Pediatric Blood & Cancer 65:7.
Crossref
Katia Perruccio, Valerio Cecinati, Angela Scagnellato, Massimo Provenzi, Giuseppe Maria Milano, Eleonora Basso, Carla Manzitti, Giovanni Cecchetto, Rita Alaggio, Martina Di Martino, Amalia Schiavetti, Fraia Melchionda, Maria Carmen Affinita, Stefano Chiaravalli, Lucia Miglionico, Rita Balter, Angela Tamburini, Gianni Bisogno & Andrea Ferrari. (2018) Biliary tract rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Associazione Italiana Ematologia Oncologia Pediatrica. Tumori Journal 104:3, pages 232-237.
Crossref
Irene Marchesi, Luca Sanna, Milena Fais, Francesco P. Fiorentino, Antonio Giordano & Luigi Bagella. (2018) 12-O-tetradecanoylphorbol-13-acetate and EZH2 inhibition: A novel approach for promoting myogenic differentiation in embryonal rhabdomyosarcoma cells. Journal of Cellular Physiology 233:3, pages 2360-2365.
Crossref
Qiang Wang, Yixuan Zhang, Mian Wang, Yi Tan, Xinxin Hu, Hongwei He, Chunling Xiao, Xuefu You, Yiguang Wang & Maoluo Gan. (2017) Neo-actinomycins A and B, natural actinomycins bearing the 5H-oxazolo[4,5-b]phenoxazine chromophore, from the marine-derived Streptomyces sp. IMB094. Scientific Reports 7:1.
Crossref
Robert Huddart, Anna Patrikidou & Stephen Hazell. 2017. Textbook of Uncommon Cancer. Textbook of Uncommon Cancer 97 121 .
Winette T A van der Graaf, Daniel Orbach, Ian R Judson & Andrea Ferrari. (2017) Soft tissue sarcomas in adolescents and young adults: a comparison with their paediatric and adult counterparts. The Lancet Oncology 18:3, pages e166-e175.
Crossref
Andrea Ferrari, Shreyaskumar R. Patel, Jay Wunder & Karen H. Albritton. 2017. Cancer in Adolescents and Young Adults. Cancer in Adolescents and Young Adults 383 416 .
Patrizia Gasparini, Michela Casanova, Raffaella Villa, Paola Collini, Rita Alaggio, Angelica Zin, Paolo Bonvini, Cristina R Antonescu, Renata Boldrini, Roberto Caserini, Massimo Moro, Giovanni Centonze, Cristina Meazza, Maura Massimino, Luca Bergamaschi, Roberto Luksch, Stefano Chiaravalli, Gianni Bisogno, Nadia Zaffaroni, MariaGrazia Daidone, Gabriella Sozzi & Andrea Ferrari. (2016) Anaplastic lymphoma kinase aberrations correlate with metastatic features in pediatric rhabdomyosarcoma. Oncotarget 7:37, pages 58903-58914.
Crossref
Willemijn B Breunis, Lianne M Haveman, Bas Vaarwerk, Emilia C Owers, Rick R van Rijn, Henk van den Berg, Jérémie F Cohen, Leontien CM Kremer, Elvira C van Dalen & Johannes HM Merks. (2016) Fluorine-18-fluorodeoxyglucose (FDG) positron emission tomography (PET) computed tomography (CT) for the detection of bone, lung and lymph node metastases in rhabdomyosarcoma. Cochrane Database of Systematic Reviews.
Crossref
Karen E. Effinger. (2015) Survival and Quality of Life Following Treatment for Sarcoma. Current Pediatrics Reports 3:2, pages 119-127.
Crossref
Steven K. M. Lau, Matthew D. Cykowski, Shiv Desai, Ying Cao, Gregory N. Fuller, Janet Bruner & Ian Okazaki. (2015) Primary Rhabdomyosarcoma of the Pineal Gland. American Journal of Clinical Pathology 143:5, pages 728-733.
Crossref
Roberta Ciarapica, Elena Carcarino, Laura Adesso, Maria De Salvo, Giorgia Bracaglia, Pier Paolo Leoncini, Alessandra Dall’Agnese, Federica Verginelli, Giuseppe M Milano, Renata Boldrini, Alessandro Inserra, Stefano Stifani, Isabella Screpanti, Victor E Marquez, Sergio Valente, Antonello Mai, Pier Lorenzo Puri, Franco Locatelli, Daniela Palacios & Rossella Rota. (2014) Pharmacological inhibition of EZH2 as a promising differentiation therapy in embryonal RMS. BMC Cancer 14:1.
Crossref
Wei-Qiang Tang, Yan Hei, Li Kang & Li-Hua Xiao. (2014) Heparanase-1 and components of the hedgehog signalling pathway are increased in untreated alveolar orbital rhabdomyosarcoma. Clinical & Experimental Ophthalmology 42:2, pages 182-189.
Crossref
Iyad Sultan, Roberta Ortiz & Andrea Ferrari. 2014. Pediatric Hematology-Oncology in Countries with Limited Resources. Pediatric Hematology-Oncology in Countries with Limited Resources 303 322 .
Carola A. S. Arndt. (2013) Risk Stratification of Rhabdomyosarcoma: A Moving Target. American Society of Clinical Oncology Educational Book:33, pages 415-419.
Crossref
Benjamin Avery Mixon, Michael J. Eckrich, Stefanie Lowas & Michael Eugene Engel. (2013) Vincristine, Irinotecan, and Temozolomide for Treatment of Relapsed Alveolar Rhabdomyosarcoma. Journal of Pediatric Hematology/Oncology 35:4, pages e163-e166.
Crossref
Carola A. S. Arndt. (2012) Role of Doxorubicin in Rhabdomyosarcoma: Is the Answer Knowable?. American Society of Clinical Oncology Educational Book:32, pages 621-623.
Crossref
Carola A.S. Arndt, Peter S. Rose, Andrew L. Folpe & Nadia N. Laack. (2012) Common Musculoskeletal Tumors of Childhood and Adolescence. Mayo Clinic Proceedings 87:5, pages 475-487.
Crossref
Robert Huddart, Stephen Hazell & Alan Horwich. 2012. Textbook of Uncommon Cancer. Textbook of Uncommon Cancer 77 96 .
Andrea FerrariCristina MeazzaMarco Vajna de PavaCarlo Alfredo ClericiMichela Casanova. (2011) Two Cases of Adolescents with Paratesticular Rhabdomyosarcoma Inadequately Treated: The Problem of Referral. Journal of Adolescent and Young Adult Oncology 1:3, pages 152-154.
Crossref
Suzanne Reed, Huameng Li, Chenglong Li & Jiayuh Lin. (2011) Celecoxib inhibits STAT3 phosphorylation and suppresses cell migration and colony forming ability in rhabdomyosarcoma cells. Biochemical and Biophysical Research Communications 407:3, pages 450-455.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.